- Home
- QNCX vs SCWO Comparison
QNCX vs SCWO Comparison
Compare QNCX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SCWO
- Stock Information
- Founded
- QNCX 2012
- SCWO 2021
- Country
- QNCX United States
- SCWO United States
- Employees
- QNCX N/A
- SCWO N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SCWO Environmental Services
- Sector
- QNCX Health Care
- SCWO Utilities
- Exchange
- QNCX Nasdaq
- SCWO Nasdaq
- Market Cap
- QNCX 44.0M
- SCWO 64.3M
- IPO Year
- QNCX 2019
- SCWO N/A
- Fundamental
- Price
- QNCX $1.02
- SCWO $0.28
- Analyst Decision
- QNCX Strong Buy
- SCWO
- Analyst Count
- QNCX 5
- SCWO 0
- Target Price
- QNCX $8.00
- SCWO N/A
- AVG Volume (30 Days)
- QNCX 138.1K
- SCWO 288.4K
- Earning Date
- QNCX 05-12-2025
- SCWO 05-14-2025
- Dividend Yield
- QNCX N/A
- SCWO N/A
- EPS Growth
- QNCX N/A
- SCWO N/A
- EPS
- QNCX N/A
- SCWO N/A
- Revenue
- QNCX N/A
- SCWO $445,445.00
- Revenue This Year
- QNCX N/A
- SCWO $5,945.19
- Revenue Next Year
- QNCX N/A
- SCWO $106.82
- P/E Ratio
- QNCX N/A
- SCWO N/A
- Revenue Growth
- QNCX N/A
- SCWO N/A
- 52 Week Low
- QNCX $0.51
- SCWO $0.25
- 52 Week High
- QNCX $2.45
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- QNCX 26.91
- SCWO 39.56
- Support Level
- QNCX $0.93
- SCWO $0.33
- Resistance Level
- QNCX $1.26
- SCWO $0.30
- Average True Range (ATR)
- QNCX 0.10
- SCWO 0.04
- MACD
- QNCX -0.03
- SCWO -0.00
- Stochastic Oscillator
- QNCX 18.03
- SCWO 14.28
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.